The Value of EEG in Stroke Units

NCT ID: NCT07190976

Last Updated: 2025-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-01

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients with acute ischemic or hemorrhagic stroke

Routine EEG

Intervention Type OTHER

The study is observational. No intervention is anticipated. Patients will be submitted to EEG recording within the first seven days of stroke

Routine EEG

Intervention Type OTHER

The study is observational

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine EEG

The study is observational. No intervention is anticipated. Patients will be submitted to EEG recording within the first seven days of stroke

Intervention Type OTHER

Routine EEG

The study is observational

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Attikon Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Panagiota Eleni Tsalouchidou

Dr. med. Panagiota Eleni Tsalouchidou

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University General Hospital "ATTIKON"- General Hospital of West Attica "H AGIA VARVARA" 2nd Neurology Clinic, NKUA

Chaïdári, Athens, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Panagiota Eleni Tsalouchidou, MD PhD

Role: primary

+30 6984158124

Zafeirenia Vlakou, MD MSc

Role: backup

+30 6940200961

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

48827/27.05.2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.